Russian Academy of Sciences (RAS)

Projects of the Russian Academy of Sciences in the field of international scientific and scientific-technical cooperation

May 18, 2021

Online International conference "COVID-19 and Thrombosis"

COVID-19 and Thrombosis and Thromboembolism

The key subjects include:

  • Thrombosis in COVID-19: a challenging incendiary duality
  • Thrombosis management in COVID-19: doing better and longer
  • Prophylaxis in non-hospitalized patients with COVID-19
  • Thrombogenic antibodies during Sars-CoV-2 infection: facts and controversies
  • COVID-19, haemostasis disorders, and thromboembolism during pregnancy
  • Covid-19 and thrombosis. Vaccination: implicat
  • COVID-19 coagulopathy-Implications for Cancer patients

Thromboembolism Prophylaxis in Patients with Severe COVID-19.

Thromboembolism prophylaxis is required for patients hospitalized with severe COVID-19; it is not required for outpatients. This topic was discussed at the International Online Conference “COVID-19 and Thrombosis Problems” held on Tuesday and attended by scientists from Austria, Canada, France, Israel, Russia, and the US. The conference was organized by the Russian Academy of Sciences.

“Maybe we should not strive for thrombosis prophylaxis in outpatients. In outpaients, pharmacological prophylaxis intended to reduce thromboembolism is likely useless given they are originally low risk. Instead, prophylaxis should aim to reduce the need for additional oxygen in hospitalized patients,” said Sam Shulman, Vice President of the International Society on Thrombosis and Haemostasis (Canada).

Professor Alex Spyropoulos, System Director of the Anticoagulation and Clinical Thrombosis Services (US), spoke on the analysis of studies describing thromboembolism and mortality statistics after COVID-19 patients’ discharge from hospital. Half of them are high-risk for thromboembolism development, 20% are low-risk. “This is why we use prophylactic strategies [to affect the development of thromboembolism],” he stressed.
Professor Benjamin Brenner (Israel) focused his presentation on the course of COVID-19 in oncological patients. “Oncological patients are high-risk for developing COVID-19 complications. Patients with hematological cancer have the worst outcome,” he said. RAS Professor Victoria O. Bitsadze, Professor of the Obstetrics and Gynecology Department at N.F. Filatov Clinical Institute of Children’s Health, said that pregnant women with COVID-19 have a higher risk of venous thromboembolism compared to pregnant women who do not have COVID-19. She spoke in favor of early administration of medications for prophylaxis of these processes.

RAS Vice President Vladimir Chekhonin said that the conference was productive and thanked the participants. “I hope we will be able to hold an in-person conference in the nearest future. We are already willing to organize it at the Russian Academy of Sciences,” he said.

Speakers

The online conference will be attended by

Ismail Elalamy

Thrombosis in COVID-19: a challenging incendiary duality.

M.D., Professor, Médecine Sorbonne Université Paris, France. President of the French Society of Angiology; Head of the Center for Thrombosis at Tenon University Hospital, Faculty of Medicine, Sorbonne University, Paris, France. Professor, Obstetrics and Gynecology Department, N.F.Filatov Clinical Institute of Children’s Health, Sechenov University.

Alex Spyropoulos

Thrombosis management in COVID-19: doing better and longer.

Professor of Medicine at Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, US. Professor of the Center for Patient-Oriented Research at the Feinstein Institutes for Medical Research. System Director, Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, US.

Sam Schulman

Prophylaxis in non-hospitalized patients with COVID-19.

MD, Professor, Department of Medicine, McMaster University, Hamilton, Canada. Professor, Thrombosis and Atherosclerosis Research Institute, Canada. Vice President of the International Society on Thrombosis and Haemostasis (ISTH). Fellow of Royal College of Physicians and Surgeons.Executive Committee member, World Federation of Hemophilia. Professor, Obstetrics and Gynecology Department, N.F.Filatov Clinical Institute of Children’s Health, Sechenov University.

Jean Christophe Gris

Thrombogenic antibodies during Sars-CoV-2 infection: facts and controversies.

MD, Professor, University Montpellier-Nîmes, France. Vice President, Thrombosis Research Center; Head, Haemostasis Pathology Laboratory; President, Medical Administrative Department for Clinical Studies and Innovations, France. Professor, Obstetrics and Gynecology Department, N.F.Filatov Clinical Institute of Children’s Health, Sechenov University.

Alexander D. Makatsariya, Victoria O. Bitsadze, Jamilya Khizroeva

COVID-19, haemostasis disorders and thromboembolism during pregnancy.

Alexander D. Makatsariya, Chair, Obstetrics and Gynecology Department, N.F.Filatov Clinical Institute of Children’s Health, Sechenov University. D.Sc. in Medicine, Academician of the Russian Academy of Sciences, Moscow, Russia.

Victoria O. Bitsadze, Professor, Obstetrics and Gynecology Department, N.F.Filatov Clinical Institute of Children’s Health, Sechenov University. D. Sc. in Medicine, Professor, Russian Academy of Sciences, Moscow, Russia

Jamilya Khizroeva, Professor, Obstetrics and Gynecology Department, N.F.Filatov Clinical Institute of Children’s Health, Sechenov University, D. Sc. in Medicine, Moscow, Russia.

Cihan Ay

COVID-19 and thrombosis. Vaccination: implicat.

MD, Professor, Medical University of Vienna, Professor, Clinical Hemostasiological Department and Comprehensive Cancer Center, Vienna, Austria. Professor, Obstetrics and Gynecology Department, N.F.Filatov Clinical Institute of Children’s Health, Sechenov University.

Benjamin Brenner

COVID-19 coagulopathy-Implications for Cancer patients.

MD, Professor, Technion’s Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel. Professor, Obstetrics and Gynecology Department, N.F.Filatov Clinical Institute of Children’s Health, Sechenov University.

Organizing Committee

Need help? Please contact the organizers!

Alexander D. Makatsariya

D.Sc. in Medicine, Academician of the Russian Academy of Sciences, the Chair of the Obstetrics and Gynecology Department at N.F.Filatov Clinical Institute of Children’s Health of Sechenov University

Sergey Malenko

Head of the International Cooperation Department of the RAS

Information partners